Exploring Effectiveness and Safety of Nimotuzumab in Recurrent or Metastatic Cervical Cancer

被引：0
|
作者：
Liu, Z. [1 ]
Zhang, J. [1 ]
Zhang, Q. [1 ]
Wang, J. [1 ]
Wang, T. [1 ]
Shi, F. [1 ]
Su, J. [1 ]
Wang, F. [1 ]
机构：
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiat Oncol, Xian, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2577
引用
收藏
页码：E259 / E259
页数：1
相关论文
共 50 条
  • [41] Predicting VTE and utility of thromboprophylaxis in metastatic and recurrent cervical cancer
    Walker, Christopher A.
    Edwards, Carson
    Mcintire, Don
    Makepeace, Lydia
    Holloway, Steven Blaine
    Kakadiaris, Ev
    Spirtos, Alexandra N.
    Miller, David S.
    Lea, Jayanthi S.
    GYNECOLOGIC ONCOLOGY, 2024, 188 : 22 - 26
  • [42] Anti-angiogenesis agents in metastatic or recurrent cervical cancer
    Monk, Bradley J.
    Willmott, Lyndsay J.
    Sumner, Daniele A.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (02) : 181 - 186
  • [43] Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancer
    Hasegawa, Kosei
    Takahashi, Shunji
    Ushijima, Kimio
    Okadome, Masao
    Yonemori, Kan
    Yokota, Harushige
    Vergote, Ignace
    Monk, Bradley J.
    Tewari, Krishnansu S.
    Fujiwara, Keiichi
    Li, Jingjin
    Jamil, Shaheda
    Paccaly, Anne
    Takehara, Kazuhiro
    Usami, Tomoka
    Aoki, Yoichi
    Suzuki, Nao
    Kobayashi, Yoichi
    Yoshida, Yoshio
    Watari, Hidemichi
    Seebach, Frank
    Lowy, Israel
    Mathias, Melissa
    Fury, Matthew G.
    Oaknin, Ana
    CANCER MEDICINE, 2024, 13 (18):
  • [44] The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer
    Tambaro, R
    Scambia, G
    Di Maio, M
    Pisano, C
    Barletta, E
    Iaffaioli, VR
    Pignata, S
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 52 (01) : 33 - 44
  • [45] A prospective study of gefitinib in patients with recurrent or metastatic cervical cancer
    Krishna, A.
    Ms, A.
    Fernandes, D.
    Ag, H.
    Rao, S.
    Shankar, S.
    Banerjee, S.
    Sunny, J.
    Srinivas, C.
    Lobo, D.
    ANNALS OF ONCOLOGY, 2022, 33 : S386 - S386
  • [46] Sintilimab plus HPV vaccine for recurrent or metastatic cervical cancer
    Wang, Buhai
    Liang, Yichen
    Wu, Yuechao
    Li, Qiuxian
    Zeng, Yichun
    Liu, Liqin
    Cao, Wenmiao
    Geng, Xiaoru
    Huang, Yuxiang
    Wu, Yinxia
    Pan, Jiulin
    Zhang, Xian
    Gu, J. Juan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (11)
  • [47] Recurrent or primary metastatic cervical cancer: current and future treatments
    Gennigens, C.
    Jerusalem, G.
    Lapaille, L.
    De Cuypere, M.
    Streel, S.
    Kridelka, F.
    Ray-Coquard, I
    ESMO OPEN, 2022, 7 (05)
  • [48] Immune checkpoint inhibitors in advanced and recurrent/metastatic cervical cancer
    Han, Xiling
    Chang, Wei-wei
    Xia, Xiaoping
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [49] Efficacy of nimotuzumab in combination with immunotherapy for a young recurrent cervical cancer patient: a case report and literature review
    Shi, Mingtao
    Zhang, Yongchun
    ANTI-CANCER DRUGS, 2024, 35 (07) : 644 - 652
  • [50] A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer
    Cetina, Lucely
    Crombet, Tania
    Jimenez-Lima, Roberto
    Zapata, Sergio
    Ramos, Mayra
    Avila, Sandra
    Coronel, Jaime
    Charco, Eduardo
    Bojalil, Rafael
    Astudillo, Horacio
    Bazan, Blanca
    Duenas-Gonzalez, Alfonso
    CANCER BIOLOGY & THERAPY, 2015, 16 (05) : 684 - 689
12345